We have sent a letter to Senate Health, Education, Labor and Pensions (HELP) Committee leadership that highlights the implications of the Verifying Accurate Leading-edge IVCT Development (VALID) Act. Because the bill would modify the regulatory framework for laboratory developed tests, the VALID Act could have serious unintended consequences for children’s health and children’s hospitals. We are asking the committee to address those concerns before advancing the Senate FDA user fee package legislation that includes the VALID Act.
VALID Act Letter
We sent a letter to Senate HELP Committee leadership to highlight the implications of the VALID Act.
Related Content
Fiscal Year 2023 Omnibus Summary
Letter to FDA on Critical Shortages Affecting Pediatric Care
House Healthy Future Task Force Requests for Information Responses
Fiscal Year 2023 Omnibus Summary
This detailed summary of the FY 2023 Omnibus focuses on those provisions of most interest to children’s hospitals.
Jan. 13, 2023
Letter to FDA on Critical Shortages Affecting Pediatric Care
CHA sent a letter to the FDA asking the agency to address two critical shortages affecting children and families.
May 11, 2022
House Healthy Future Task Force Requests for Information Responses
CHA has submitted responses to several RFIs from the House Healthy Future Task Force.
March 11, 2022
